Sanofi Earns Slump in Q3 as Competition Heats Up
Sanofi earns slump in Q3 as competition heats up
Filed under: drug treatment news stories
PARIS (AP) — Sanofi says earnings slumped in the third quarter as generic competitors ate into profits of its Eloxatin cancer treatment. The French drug maker reported net profit of (euro) 1.6 billion ($ 2.1 billion) for the July-September quarter …
Read more on WPEC
Zimbabwe nurses to initiate HIV, Aids treatment
Filed under: drug treatment news stories
“We have heard numerous stories of drug stockouts in some provinces, of people on treatment sharing drugs, and of even drugs expiring while some people are dying from lack of access to treatment. This is very disturbing and it must be addressed …
Read more on NewsDay
Factiva RTF Display Format – ADSL & ADSL2+ Broadband Plans …
Another plus: It faces competition mostly from mom-and-pops; the top five U.S. sporting goods All this means that when the market for microcaps heats up, as it did for a seven-year commercial real estate would hit the skids and housing would suffer only a brief slump. So in 2006 he beefed up … View Document
Quincy Herald-Whig | Illinois & Missouri News, SportsSanofi Earns Slump In Q3 As Competition Heats Up
PARIS (AP) – Sanofi saw its earnings slump in the third quarter as generic competitors ate into profits of its Eloxatin cancer treatment. The French drug maker reported Thursday net profit of €1.6 billion ($2.1 billion) for the July-September quarter, down 20% from €2 billion a year earlier. … Read News
Sanofi Earns Slump In Q3 As Competition Heats Up
Sanofi saw its earnings slump in the third quarter as generic competitors ate into profits of its Eloxatin cancer treatment. … Read News